Clinical Trials Logo

Filter by:
NCT ID: NCT01605383 Completed - Clinical trials for Avascular Necrosis of Femur Head

Mesenchymal Stem Cells in Osteonecrosis of the Femoral Head

Start date: May 5, 2015
Phase: Phase 1/Phase 2
Study type: Interventional

The present study evaluates the effect of XCEL-MT-OSTEO-ALPHA in osteonecrosis of the femoral head in comparison to the standard treatment of isolated core decompression. XCEL-MT-OSTEO-ALPHA is a tissue engineering product composed by "ex-vivo" expanded autologous mesenchymal stem cells fixed in allogenic bone tissue. The working hypothesis proposes that the tissue engineering is a valid and useful technique to achieve bone regeneration, avoiding the progression to collapse of the femoral head.

NCT ID: NCT01605279 Completed - Clinical trials for Hemodynamic Instability

Dobutamine Versus Placebo for Low Superior Vena Cava Flow in Newborns

Start date: September 2010
Phase: Phase 2
Study type: Interventional

Low systemic flow as measured by Doppler-echocardiography has been associated with poor neurological outcome. Yet, it has not been systematically evaluated whether the treatment of this hemodynamic condition is beneficial or not. This study aims to evaluate if treating low systemic flow in preterm infants with dobutamine has any effect on the cerebral circulation and in newborn prognosis.

NCT ID: NCT01605227 Completed - Prostate Cancer Clinical Trials

Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100

COMET-1
Start date: July 2012
Phase: Phase 3
Study type: Interventional

This study will evaluate the effect of cabozantinib compared to prednisone on overall survival in men with previously treated metastatic castration-resistant prostate cancer with bone-dominant disease who have experienced disease progression on docetaxel-containing chemotherapy and abiraterone or MDV3100.

NCT ID: NCT01604928 Completed - Clinical trials for Urinary Bladder, Overactive

Study to Test the Efficacy and Safety of YM178 in Subjects With Symptoms of Overactive Bladder

Blossom
Start date: April 2004
Phase: Phase 2
Study type: Interventional

The study is intended to test efficacy, safety and tolerability of two doses of YM178 against placebo and tolterodine to treat patients with symptoms of over active bladder.

NCT ID: NCT01604811 Completed - Clinical trials for Benign Prostatic Hyperplasia (BPH)

Exploratory Study of L.S.E.S.r. (LipidoSterolic Extract of Serenoa Repens)(PERMIXON® 160 mg Hard Capsule) Versus Tamsulosine LP Activity on Inflammation Biomarkers in Urinary Symptoms Related to BPH (Benign Prostatic Hyperplasia)

PERMIN
Start date: June 2012
Phase: Phase 4
Study type: Interventional

Inflammation is reported as one of the most recent hypotheses to explain BPH. Recent published works pointed out that urine and serum markers could be used for detection of prostatic inflammation. The aim of the study is to assess the activity on inflammation biomarkers (serum and urine inflammation markers) of Permixon® 160 mg hard capsule and Tamsulosine Arrow LP in the treatment of urinary symptoms related to BPH. The potential links between serum and urinary markers of inflammation and BPH clinical symptoms at baseline and on treatment will be explored.

NCT ID: NCT01604629 Completed - Clinical trials for Spondylarthropathies

Evaluation of a Protocol for Dose Reduction in Patients With Spondylarthropathies and Clinical Remission With Anti-TNF

REDES-TNF
Start date: July 2012
Phase: Phase 4
Study type: Interventional

The purpose of this study is to demonstrate that patients with Spondylarthropathies in remission under antiTNF therapy, can maintain the remission with a maintenance dose inferior to the currently recommended dose schedule.

NCT ID: NCT01604278 Completed - Clinical trials for Chronic Obstructive Pulmonary Disease (COPD)

Efficacy, Safety and Tolerability of the Co-administration of NVA237 Plus Indacaterol Once Daily Versus Indacaterol Once Daily in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)

GLOW6
Start date: May 2012
Phase: Phase 3
Study type: Interventional

This study assessed the efficacy, safety and tolerability of the co-administration of NVA237 plus indacaterol taken once daily versus indacaterol taken once daily in patients with moderate to severe Chronic Obstructive Pulmonary Disease.

NCT ID: NCT01604174 Completed - Knee Osteoarthritis Clinical Trials

Interactive Virtual Telerehabilitation After Total Knee Arthroplasty

REHABITIC
Start date: November 2008
Phase: N/A
Study type: Interventional

The purpose of this clinical trial is to compare the effectiveness of a new interactive virtual telerehabilitation (IVT) system with the conventional program in the rehabilitation of patients after total knee arthroplasty.

NCT ID: NCT01604083 Completed - Surgery Clinical Trials

European Transfusion Practice and Outcome Study

ETPOS
Start date: April 2013
Phase:
Study type: Observational

The aim of the ETPOS study is to describe differences in transfusion habits throughout Europe and to correlate these habits to perioperative outcome parameters. Special focus is put on the number of PRBCs (packed red blood cells) transfused and the ratio of PRBCs to other blood products or coagulation factors in the operating room. Furthermore the motivation of physicians to transfuse PRBC and blood products in the operating room will be investigated.

NCT ID: NCT01603680 Completed - Anesthesia Clinical Trials

Distribution Circumferential Versus Non Circumferential of Mepivacaine in the Median and Ulnar Nerves

Start date: January 2012
Phase: Phase 4
Study type: Interventional

1. Evaluation of the efficacy of the circumferential versus non circumferential distribution of mepivacaine around the median and ulnar nerves. 2. Evaluation the onset of action of mepivacaine in circumferential versus non circumferential distribution around the median and ulnar nerves. 3. Spread of mepivacaine after injection guided by ultrasonography. 4. Complications of both anesthetic techniques in postoperative time.